Drugs.com - Pharma Industry News

Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma

THURSDAY, April 24, 2025 -- For patients with unresectable metastatic uveal melanoma (mUM), the drug/device combination melphalan/hepatic delivery system (HDS) is efficacious and has a favorable risk-benefit profile compared with best alternative...

Apr 24, 2025 - 18:13
 0
Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma
THURSDAY, April 24, 2025 -- For patients with unresectable metastatic uveal melanoma (mUM), the drug/device combination melphalan/hepatic delivery system (HDS) is efficacious and has a favorable risk-benefit profile compared with best alternative...
Read More

Tags:

Previous Article

Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis

Next Article

Single-Dose Baloxavir Treatment Can Reduce Influenza Transmission

Related Posts

Dobbs Decision Has Negatively Impacted Access to OB/GYN Practitioners

Dobbs Decision Has Negatively Impacted Access to OB/GYN...

Mar 14, 2025  0

Survey Reveals Women May Be Experiencing Perimenopause in Their 40s

Survey Reveals Women May Be Experiencing Perimenopause ...

Apr 25, 2025  0

States That Adopted Abortion Bans Have Higher Infant Mortality

States That Adopted Abortion Bans Have Higher Infant Mo...

Feb 26, 2025  0